AstraZeneca CEO says new global trial on COVID-19 vaccine likely
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine candidate, the company's CEO tells Bloomberg.
Full Article
AstraZeneca CEO says new global trial on COVID-19 vaccine likely
CBC.ca
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Milestone Scientific, Loncor Resources, LeanLife, Genprex, BioSig Technologies UPDATE...
Proactive Investors
Milestone Scientific Inc (NYSEAMERICAN:MLSS) president Arjan Haverhals said Monday that the developer of computerized drug delivery..
-
Serum Institute files Rs 100 crore defamation case after man says vaccine left him ill
Mid-Day
-
AstraZeneca Likely To Run New Global Trial Of COVID-19 Vaccine
RTTNews
-
FTSE 100 Slides As Brexit Talks Drag On
RTTNews
-
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
Advertisement
More coverage
AstraZeneca to launch a new global trial for its COVID-19 vaccine
Invezz
In a statement on Thursday, CEO Pascal Soriot of AstraZeneca plc (LON: AZN) expressed plans of launching a new global trial that..